Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection

Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection

Abstract Pulmonary hypertension (PH) complicates the treatment of interstitial lung disease (ILD) patients resulting in poor functional status and worse outcomes. Early recognition of PH in ILD is important for initiating therapy and considering lung transplantation. However, no standard exists rega...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Raj Parikh, Ippokratis Konstantinidis, David M. O'Sullivan, Harrison W. Farber
स्वरूप:	लेख
भाषा:	English
प्रकाशित:	Wiley 2022-10-01
श्रृंखला:	Pulmonary Circulation
विषय:	idiopathic pulmonary fibrosis interstitial lung disease prostacyclin pulmonary hypertension treprostinil
ऑनलाइन पहुंच:	https://doi.org/10.1002/pul2.12141

समान संसाधन

The PH‐ILD Detection tool: External validation and use in patients with ILD
द्वारा: Raj Parikh, और अन्य
प्रकाशित: (2023-07-01)

Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients
द्वारा: Julia McSweeney, और अन्य
प्रकाशित: (2023-04-01)

Evaluation of patients with severe pulmonary hypertension and a range of comorbidities prescribed inhaled treprostinil
द्वारा: Aparna C. Swaminathan, और अन्य
प्रकाशित: (2024-11-01)

Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration
द्वारा: Jenna M. Faircloth, और अन्य
प्रकाशित: (2023-03-01)

Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration
द्वारा: Jenna M. Faircloth, और अन्य
प्रकाशित: (2023-08-01)

The Importance of Dose Escalation in the Treatment of Pulmonary Arterial Hypertension with Treprostinil
द्वारा: Piotr Kędzierski, और अन्य
प्रकाशित: (2025-01-01)

Inhaled therapies targeting prostacyclin pathway in pulmonary hypertension due to COPD: systematic review
द्वारा: Abdullah A. Alqarni, और अन्य
प्रकाशित: (2023-08-01)

INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)
द्वारा: Nicholas S. Hill, और अन्य
प्रकाशित: (2022-07-01)

Real‐world use of inhaled treprostinil for lung disease‐pulmonary hypertension: A protocol for patient evaluation and prescribing
द्वारा: Shelsey W. Johnson, और अन्य
प्रकाशित: (2022-07-01)

Unexpected Acceleration in Treprostinil Delivery Administered by a Lenus Pro® Implantable Pump in Two Patients Treated for Pulmonary Arterial Hypertension
द्वारा: Garance Kopp, और अन्य
प्रकाशित: (2020-10-01)

Reasons for refusing parenteral therapy: a qualitative study of patients with pulmonary arterial hypertension
द्वारा: Kellie Morland, और अन्य
प्रकाशित: (2021-10-01)

Combination therapy with riociquat and inhaled treprostinil in inoperable and progressive chronic thromboembolic pulmonary hypertension
द्वारा: John W. Swisher, PhD, MD, और अन्य
प्रकाशित: (2017-01-01)

Evolution of pulmonary hypertension in interstitial lung disease: a journey through past, present, and future
द्वारा: Ahmad Arslan, और अन्य
प्रकाशित: (2024-01-01)

PAH-specific therapy for pulmonary hypertension and interstitial lung disease: A systemic review and meta-analysis
द्वारा: Ning Zhao, और अन्य
प्रकाशित: (2022-11-01)

Predictors of mortality in interstitial lung disease patients without pulmonary hypertension
द्वारा: Esam H Alhamad, और अन्य
प्रकाशित: (2020-01-01)

Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia
द्वारा: Maria S. Nashatyreva, और अन्य
प्रकाशित: (2023-01-01)

Prostacyclin receptor agonist selexipag in a patient with high-risk idiopathic pulmonary arterial hypertension: a case report
द्वारा: E. A. Rezukhina, और अन्य
प्रकाशित: (2021-09-01)

Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis
द्वारा: Lianghua Xiao, और अन्य
प्रकाशित: (2024-09-01)

Periprocedural safety and outcome after pump implantation for intravenous treprostinil administration in patients with pulmonary arterial hypertension
द्वारा: Jan C. Kamp, और अन्य
प्रकाशित: (2021-05-01)

Estimation of plasmic concentration of the brain natriuretic peptide in interstitial pulmonary diseases with pulmonary hypertension: clinical role
द्वारा: N A Mukhin, और अन्य
प्रकाशित: (2009-03-01)

Abnormal platelet aggregation in pediatric pulmonary hypertension
द्वारा: Stephanie S. Handler, और अन्य
प्रकाशित: (2022-07-01)

Selexipag in the treatment of pulmonary arterial hypertension: design, development, and therapy
द्वारा: Hardin EA, और अन्य
प्रकाशित: (2016-11-01)

Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy
द्वारा: Donna Steinbacher, और अन्य
प्रकाशित: (2024-04-01)

The effects of standardized intravenous treprostinil in pulmonary arterial hypertension patients after total cavo-pulmonary connection procedure
द्वारा: Xiaofeng Wang, और अन्य
प्रकाशित: (2024-10-01)

Prostacyclin pathway vasodilators in patients with chronic thromboembolic pulmonary hypertension (CTEPH): A systemic review and meta‐analysis of randomized controlled trials
द्वारा: Weijun Li, और अन्य
प्रकाशित: (2024-10-01)

New Era of Management Concept on Pulmonary Fibrosis with Revisiting Framework of Interstitial Lung Diseases
द्वारा: Arata Azuma, और अन्य
प्रकाशित: (2020-07-01)

Hemodynamic assessment of transitioning from parenteral prostacyclin to selexipag in pediatric pulmonary hypertension
द्वारा: Elizabeth Colglazier, और अन्य
प्रकाशित: (2022-10-01)

The application of metabolomics toward idiopathic pulmonary fibrosis and potential metabolomic value of diverse samples in interstitial lung diseases
द्वारा: Mingtao Liu, और अन्य
प्रकाशित: (2023-09-01)

CLINICAL PROFILE OF INTERSTITIAL LUNG DISEASES CASES
द्वारा: Gagiya Ashok K, और अन्य
प्रकाशित: (2012-03-01)

Pulmonary hypertension associated with chronic lung diseases
द्वारा: Manuela Funke, और अन्य
प्रकाशित: (2016-09-01)

Therapeutic Potential of Treprostinil Inhalation Powder for Patients with Pulmonary Arterial Hypertension: Evidence to Date
द्वारा: Cassady SJ, और अन्य
प्रकाशित: (2024-06-01)

Comparison of treprostinil and oral sildenafil for the treatment of persistent pulmonary hypertension of the newborn: a retrospective cohort study
द्वारा: Enhuan Wei, और अन्य
प्रकाशित: (2023-11-01)

Congruency between clinician‐assessed risk and calculated risk of 1‐year mortality in patients with pulmonary arterial hypertension: A retrospective chart review
द्वारा: Amresh Raina, और अन्य
प्रकाशित: (2024-10-01)

Pulmonary hypertension secondary to interstitial fibrosis with pulmonary venous lesions masquerading pulmonary veno‐occlusive disease
द्वारा: Hiroki Nakayama, और अन्य
प्रकाशित: (2023-07-01)

Younger age at initiation of subcutaneous treprostinil is associated with better response in pediatric Group 1 pulmonary arterial hypertension
द्वारा: Justin J. Kochanski, और अन्य
प्रकाशित: (2024-01-01)

Interstitial lung diseases with progressive pulmonary fibrosis: pathogenetic features and approaches to therapy
द्वारा: N. A. Kuzubova, और अन्य
प्रकाशित: (2020-11-01)

Management of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)
द्वारा: Carla R. Copeland, और अन्य
प्रकाशित: (2021-10-01)

Safety and tolerability of continuous inhaled iloprost in critically ill pediatric pulmonary hypertension patients: A retrospective case series
द्वारा: Elizabeth Colglazier, और अन्य
प्रकाशित: (2023-07-01)

Incidence and Clinical Characteristics of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
द्वारा: Wei Yan, और अन्य
प्रकाशित: (2015-01-01)

Interstitial Lung Abnormality in Asian Population
द्वारा: Gong Yong Jin
प्रकाशित: (2024-04-01)